Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation

BACKGROUND: Protein markers of cellular proliferation, hypoxia, apoptosis, cell cycle checkpoints, growth factor signalling and inflammation in localised prostate tumours have previously shown prognostic ability. A translational substudy within the CHHiP trial of radiotherapy fractionation evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkins, Anna, Gusterson, Barry, Tovey, Holly, Griffin, Clare, Stuttle, Christine, Daley, Frances, Corbishley, Catherine M., Dearnaley, David, Hall, Emma, Somaiah, Navita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900483/
https://www.ncbi.nlm.nih.gov/pubmed/36708693
http://dx.doi.org/10.1016/j.ebiom.2023.104436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900483/
https://www.ncbi.nlm.nih.gov/pubmed/36708693
http://dx.doi.org/10.1016/j.ebiom.2023.104436

Ejemplares similares